The Governor-General has announced the 2025 Australia Day Honours List, with several members of the Griffith University community recognised for...
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
A state-of-the-art livecyte microscope at the Griffith Institute for Drug Discovery is leading the Spinal Injury Project team toward human clinical trials.
Griffith University’s world-first study into cell transplantation to repair injuries to the nervous system has received a major boost thanks to a $5.4 million funding extension from the MAIC.
A new world order Stan Grant has built an illustrious career as a distinguished Australian and international broadcaster, author and...
Join Stan and Kerry as they explore the opportunities and challenges facing our rapidly and unpredictable changing world order, and what the future might hold for all Australians.
2021 Australia Dayhonourshave been bestowed upona number ofGriffith Universitystaff, associates and alumni.
An Australian-first rehabilitation trial considered the next crucial step in treating paralysis will proceed after a record donation from the country’s leading spinal injury research foundation.
World-leading Griffith research into the development of a cell-based therapy for treating spinal cord injuries has received a $5.7m boost from the state government.
Invited to join the UK Civil Service's Fast Stream graduate program, Griffith University alumnus James Boyle is part of a fascinating era for British politics
